NCT06511180View on ClinicalTrials.gov

Introduction of Dispersible 3HP Formulations for TB Preventive Treatment in Children: a Multi-country Evaluation

Not yet recruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
TB - TuberculosisHousehold ContactHIVChildren, Only
All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

collaborator

KNCV Tuberculosis Foundation

OTHER

collaborator

Clinton Health Access Initiative Inc.

OTHER

lead

The Aurum Institute NPC

OTHER